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Coagulation Disorders After Reperfusion of Pancreatic Allografts 
A. Nader, M. Busing, I. Blumenstock, N. Heimburger, M. Jochum, and U.T. Hopt 
THE use of pancreaticoduodenal grafts instead of seg-mental pancreatic grafts has markedly reduced the 
incidence of early postoperative graft thrombosis. Never-
theless there is still a significant number of pancreatic 
grafts that are lost in the early postoperative period due to 
graft thrombosis.1 Graft thrombosis seems to be a specific 
problem of pancreas grafts; it is nearly unknown in kidney 
transplantation. 
The reasons for this problem are certainly multifactorial. 
Besides technical problems and low blood flow within the 
graft itself, the typical ischemia/reperfusion injury2 result-
ing in tissue edema and severe damage of the endothelial 
cells within the graft must be taken into account. Up to 
now, however, it has not been completely clear whether 
local or generalized disorders of the coagulation system 
might be crucial in this respect. To clarify this question, a 
prospective study was conducted. 
MATERIALS AND METHODS 
A consecutive series of 10 patients with bladder-drained pancre-
aticoduodenal and renal allografts3 was studied. The grafts were 
perfused with 2000 to 3000 m L of University of Wisconsin 
solution. The portal vein and the celiac axis were reconstructed 
with vascular grafts from the donor. Cold ischemia time ranged 
between 8 and 16 hours. Quadruple immunosuppressive therapy 
was used in all patients. Anticoagulation therapy was started with 
low-dose heparin and low molecular weight dextran only 10 hours 
after reperfusion of the graft. Antithrombin III (AT III) was 
substituted starting 4 to 6 hours after reperfusion in order to 
achieve plasma levels of >80%. 
Starting 30 minutes before reperfusion until the 10th postoper-
ative day, the following parameters were analysed: prothrombin, 
A T I I I , thrombin-antithrombin I I I complexes (TAT) , coagulation 
Factor X I I I , and fibrin D dimers. 
RESULTS AND DISCUSSION 
Immediately after reperfusion of the pancreatic grafts, a 
dramatic consumption of prothrombin could be found. Six 
hours after reperfusion, prothrombin activity was reduced 
to 55% in the average graft, indicating an immediate and 
strong activation of the coagulation cascade in these pa-
tients. Normalization of the prothrombin activity was not 
seen before the 2nd postoperative day. 
The high amounts of thrombin, which result from the 
strong activation of prothrombin as shown before, were 
bound in part to AT I I I , the most important physiological 
thrombin inhibitor. Thus, AT I I I levels in plasma dramat-
ically decreased immediately after reperfusion of the pan-
creatic graft. AT I I I levels <40% could be found in single 
cases despite early AT I I I substitution, indicating a signif-
icantly increased risk of spontaneous thrombosis in these 
patients.4 As one would expect, plasma TAT levels in-
creased up to 20-fold above normal at the same time. 
Again, normalization was not seen before the first 24 hours 
after reperfusion. 
Coinciding with the strong hypercoagulability seen in 
these patients, fibrinolysis also was activated. Thus, fibrin-
D-dimers started to increase 2 hours after reperfusion and 
reached their maximal value 10 hours later. Contrary to the 
activation of the coagulation cascade, activated fibrinoly-
sis could be demonstrated only in one fourth of the 
patients. 
Coagulation Factor X I I I , which is necessary for stabili-
zation of fibrin, dropped dramatically immediately after 
reperfusion as the parameters mentioned before. How-
ever, recovery of Factor X I I I plasma levels took more 
than 10 days, suggesting that ongoing nonspecific destruc-
tion of the Factor f.e. by PMN-elastase might occur in 
these patients. 
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Taken together, these results demonstrate that pancre-
atic transplantation induces a state of hypercoagulability in 
the early postoperative period in nearly all patients. This is 
followed by reactive hyperfibrinolysis in some patients. It 
is tempting to assume that lesions within the graft that are 
induced by ischemia/reperfusion injury and resemble the 
picture of genuine pancreatitis are responsible for this 
phenomenon.5,6 This hypercoagulability might well be one 
of the key factors in development of early postoperative 
graft thrombosis. Thus, at least in our opinion, anticoagu-
lation with low-dose heparin and aggressive substitution of 
AT I I I seems to be advisable in pancreatic transplantation. 
By using this therapeutic regimen in a consecutive series of 
65 patients, we did not see any graft thrombosis at all, 
resulting in a 1-year graft function rate of 90%. 
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